Feasibility of the adapted LiFE (aLiFE) intervention – a pilot study

ISRCTN ISRCTN37750605
DOI https://doi.org/10.1186/ISRCTN37750605
Secondary identifying numbers N/A
Submission date
21/04/2016
Registration date
03/05/2016
Last edited
15/04/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
A new behaviour change exercise programme named “adapted Lifestyle-integrated Exercise Program (aLiFE)” has been developed within the EU-funded project “PreventIT” (http://www.preventit.eu/). This study aims to evaluate the feasibility of the new aLiFE programme in young older adults aged 60-70.

Who can participate?
Community-dwelling men and women aged 60 to 70

What does the study involve?
The aLiFE programme is delivered by a specialist instructor during 4 home visits. The instructor teaches the participants balance and strength exercises which they can incorporate into their daily life. Participants are also taught to increase their physical activity level. Before and after the intervention participants undergo an assessment of their functional performance. After the intervention, participants are asked about their opinions regarding the aLiFE training.

What are the possible benefits and risks of participating?
Participants may benefit from the intervention in terms of improving their functional performance and increasing their physical activity, although this is not the aim of this study. The aim is to evaluate the participants’ opinions about the programme. The risk of adverse events during aLiFE training is estimated to be low.

Where is the study run from?
1. Robert-Bosch Hospital Stuttgart (Germany)
2. VU University Medical Center Amsterdam (Netherlands)
3. Norwegian University of Science and Technology (Norway)

When is the study starting and how long is it expected to run for?
January 2016 to December 2016

Who is funding the study?
European Commission Horizon 2020

Who is the main contact?
Dr Michael Schwenk

Contact information

Dr Michael Schwenk
Scientific

Robert-Bosch-Krankenhaus
Abteilung für Geriatrie und Klinik für Geriatrische Rehabilitation
Auerbachstr. 110
Stuttgart
70376
Germany

Study information

Study design4-week one-group pre-post test intervention study
Primary study designInterventional
Secondary study designPre-post test
Study setting(s)Community
Study typePrevention
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleFeasibility of the adapted Lifestyle-integrated Exercise (aLiFE) Programme for improving functional performance and increasing physical activity in young older adults: a multicentre pilot study
Study acronymaLiFE pilot
Study hypothesisPrimary hypothesis: a newly developed adapted Lifestyle-integrated Exercise (aLiFE) Programme is feasible and well accepted in a sample of young older adults who are 60 to 70 years of age.

A secondary aim is to test the feasibility of different balance scales in young old adults regarding appropriateness, ceiling effects, and reliability in the target population.
Ethics approval(s)1. Stuttgart: Ethik-Kommission am Universitätsklinikum Tübingen, 07/04/2016, 033/2016BO2
2. Amsterdam: Medical Ethical Committee, VU University Medical Center, 13/04/2016, NL56456.029.16
3. Trondheim: REC central, anticipated date of approval 29/04/2016, central midt 2016/48
ConditionPreventing functional decline in older adults
InterventionThe adapted Lifestyle-integrated Exercise (aLiFE) programme is an adapted version of the LiFE programme developed by Clemson et al. (BMJ 2012;345:e4547). aLiFE includes strength, balance, and physical activities integrated in everyday life, so that the activities can be performed in natural settings multiple times throughout the day. The aLiFE programme has been specifically adapted to fit people between 60 to 70 year of age.
Intervention typeBehavioural
Primary outcome measureFeasibility of aLiFE as defined by:
1. Willingness to participate
2. Adherence
3. Possible harms
4. Acceptability (rating of helpfulness, safety, level of difficulty, and adaptability)
5. Participants’ views on:
5.1. Planning and engaging in aLiFE activities
5.2. The aLiFE manual
5.3. Support from the trainers
5.4. Their ideas for improving the programme (semi-structured interviews)
Secondary outcome measuresAppropriateness of balance scales in the population of young old adults (ceiling effects, reliability)
Overall study start date01/01/2016
Overall study end date21/12/2016

Eligibility

Participant type(s)Healthy volunteer
Age groupSenior
SexBoth
Target number of participants30
Total final enrolment51
Participant inclusion criteriaCommunity dwelling men and women at age 60 to 70 years
Participant exclusion criteria1. Inability to walk 500 meters without aid
2. Cognitive impairment (Montreal Cognitive Assessment, MOCA ≥24 points)
3. Existence of severe cardiovascular, pulmonary, neurological, or mental disease where exercise is contraindicated
4. Attending organised exercise classes more than twice a week and/or not exercising more than 2 hours on their own each week
Recruitment start date01/05/2016
Recruitment end date31/08/2016

Locations

Countries of recruitment

  • Germany
  • Netherlands
  • Norway

Study participating centres

Robert-Bosch Hospital Stuttgart
70376
Germany
VU University Medical Center Amsterdam
1007
Netherlands
Norwegian University of Science and Technology
7491
Norway

Sponsor information

Robert-Bosch Hospital Stuttgart (Germany)
Hospital/treatment centre

Auerbachstr. 110
Stuttgart
70376
Germany

ROR logo "ROR" https://ror.org/034nkkr84

Funders

Funder type

Other

European Commission Horizon 2020

No information available

Results and Publications

Intention to publish date21/12/2017
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planTo be confirmed at a later date
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 03/07/2018 Yes No
Results article results 01/07/2019 15/04/2020 Yes No

Editorial Notes

15/04/2020: The following changes have been made:
1. Publication reference added.
2. The total final enrolment number has been added from the 2018 reference.
05/03/2019: Publication reference added.
12/10/2017: internal review.